Multiple Sclerosis Trial, Recruiting NCT06072703 Sponsor: The Methodist Hospital Research Institute Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06072703
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman aged 18 or older
  • You have Multiple Sclerosis (MS) that has been stable, meaning your condition has not gotten significantly worse in the last 6 months, and your disability level is within a certain range (confirm with trial site)
  • You have been experiencing bladder control problems related to your nervous system for at least 3 months, and these symptoms score at a certain level on a standard questionnaire (confirm with trial site)
  • You have scored above 10 on a standard memory and thinking assessment (confirm with trial site)
  • You have at least one bladder storage problem, such as needing to urinate frequently, feeling sudden strong urges to urinate, waking at night to urinate, or experiencing leakage
  • If you currently have a urinary tract infection (UTI), you may still be eligible after it has been treated and cleared

Who may not be able to join:

  • You are pregnant, trying to become pregnant, or currently breastfeeding
  • Tests have shown that your bladder has a blockage in the outlet
  • You have a Baclofen pump, any other pump that delivers medicine directly to the spine, or a pacemaker
  • You have a personal or immediate family history of seizures, or you take certain medications or drink heavily in ways that could increase the risk of seizures (such as the medication Wellbutrin/bupropion)
  • You have a history of bipolar disorder, or you take certain medications such as antidepressants, antipsychotics, lithium, Wellbutrin, or antihistamines that could affect this condition
  • You have any lesions inside the skull or have had a bleeding stroke
  • You have a moderate to severe heart condition or unstable chest pain (angina)
  • You have a history of a condition called Autonomic Dysreflexia, which involves sudden dangerous changes in blood pressure (confirm with trial site)
  • You have a history of a painful bladder condition called interstitial cystitis, or have had radiation treatment to the pelvic area
  • You have received Botox injections into the bladder muscle within the last 6 months
  • You are currently incarcerated
  • You have an active nerve stimulation device in the sacral area or any other active spinal stimulator
  • You have a permanent catheter inserted into your bladder through the urethra or abdomen

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rose Khavari, MD, The Methodist Hospital Research Institute

Phone: 7137030660

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Methodist Hospital Research Institute
Registry
ClinicalTrials.gov
Start date
30 October 2023
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in subjective clinical outcomes following treatment - Neurogenic Bladder Symptom Score (NBSS) Questionnaire; Changes on patient reported outcomes following treatment - 2 day bladder diary

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov